Literature DB >> 16407218

Interaction of mannan binding lectin with alpha2 macroglobulin via exposed oligomannose glycans: a conserved feature of the thiol ester protein family?

James N Arnold1, Russell Wallis, Antony C Willis, David J Harvey, Louise Royle, Raymond A Dwek, Pauline M Rudd, Robert B Sim.   

Abstract

The serum collectin mannan-binding lectin (MBL) binds to oligomannose and GlcNAc-terminating glycans present on microorganisms. Using a commercial affinity chromatography resin containing immobilized MBL we screened human and mouse serum for endogenous MBL-binding targets. We isolated the serum protease inhibitor alpha(2) macroglobulin (alpha2M), a heavily glycosylated thiol ester protein (TEP) composed of four identical 180-kDa subunits, each of which has eight N-linked glycosylation sites. alpha2M has previously been reported to interact with MBL; however, the interaction was not characterized. We investigated the mechanism of formation of complexes between alpha2M and MBL and concluded that they form by the direct binding of oligomannose glycans Man(5-7) occupying Asn-846 on alpha2M to the lectin domains (carbohydrate recognition domains) of MBL. The oligomannose glycans are accessible for lectin binding on both active alpha2M (thiol ester intact) and protease-cleaved alpha2M (thiol ester cleaved). We demonstrate that MBL is able to interact with alpha2M in the fluid phase, but the interaction does not inhibit the binding of MBL to mannan-coated surfaces. In addition to alpha2M, two other members of the TEP family, C3 and C4, which also contain oligomannose glycans, were captured from human serum using the MBL resin. MBL binding may be a conserved feature of the TEPs, dating from their ancestral origins. We suggest that the inhibition of proteases on the surface of microorganisms by an ancestral alpha2M-like TEP may generate "arrays" of oligomannose glycans to which MBL or other lectins can bind. Binding would lead to opsonization or activation of enzyme systems such as complement.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16407218     DOI: 10.1074/jbc.M511432200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  12 in total

1.  Anti-Ebola MAb 17A3 reacts with bovine and human alpha-2-macroglobulin proteins.

Authors:  Jae-Sung Yu; Ben-Jiang Ma; Richard M Scearce; Hua-Xin Liao; Barton F Haynes
Journal:  J Virol Methods       Date:  2010-05-04       Impact factor: 2.014

2.  A Method for Comprehensive Glycosite-Mapping and Direct Quantitation of Serum Glycoproteins.

Authors:  Qiuting Hong; L Renee Ruhaak; Carol Stroble; Evan Parker; Jincui Huang; Emanual Maverakis; Carlito B Lebrilla
Journal:  J Proteome Res       Date:  2015-11-09       Impact factor: 4.466

3.  Surfactant protein D interacts with alpha2-macroglobulin and increases its innate immune potential.

Authors:  Hayley A Craig-Barnes; Barbara S Doumouras; Nades Palaniyar
Journal:  J Biol Chem       Date:  2010-03-05       Impact factor: 5.157

4.  N-glycans in liver-secreted and immunoglogulin-derived protein fractions.

Authors:  S Bekesova; O Kosti; K B Chandler; J Wu; H L Madej; K C Brown; V Simonyan; R Goldman
Journal:  J Proteomics       Date:  2012-02-03       Impact factor: 4.044

5.  Galectin-1-binding glycoforms of haptoglobin with altered intracellular trafficking, and increase in metastatic breast cancer patients.

Authors:  Michael C Carlsson; Cecilia Cederfur; Viveka Schaar; Crina I A Balog; Adriana Lepur; Franck Touret; Emma Salomonsson; André M Deelder; Mårten Fernö; Håkan Olsson; Manfred Wuhrer; Hakon Leffler
Journal:  PLoS One       Date:  2011-10-18       Impact factor: 3.240

6.  Connecting genetic risk to disease end points through the human blood plasma proteome.

Authors:  Karsten Suhre; Matthias Arnold; Aditya Mukund Bhagwat; Richard J Cotton; Rudolf Engelke; Johannes Raffler; Hina Sarwath; Gaurav Thareja; Annika Wahl; Robert Kirk DeLisle; Larry Gold; Marija Pezer; Gordan Lauc; Mohammed A El-Din Selim; Dennis O Mook-Kanamori; Eman K Al-Dous; Yasmin A Mohamoud; Joel Malek; Konstantin Strauch; Harald Grallert; Annette Peters; Gabi Kastenmüller; Christian Gieger; Johannes Graumann
Journal:  Nat Commun       Date:  2017-02-27       Impact factor: 14.919

7.  Identification of serum glycoprotein ligands for the immunomodulatory receptor blood dendritic cell antigen 2.

Authors:  Jong-Won Kim; James Budzak; Yu Liu; Sabine A F Jégouzo; Kurt Drickamer; Maureen E Taylor
Journal:  Glycobiology       Date:  2018-08-01       Impact factor: 4.313

8.  Intracellular reprogramming of expression, glycosylation, and function of a plant-derived antiviral therapeutic monoclonal antibody.

Authors:  Jeong-Hwan Lee; Da-Young Park; Kyung-Jin Lee; Young-Kwan Kim; Yang-Kang So; Jae-Sung Ryu; Seung-Han Oh; Yeon-Soo Han; Kinarm Ko; Young-Kug Choo; Sung-Joo Park; Robert Brodzik; Kyoung-Ki Lee; Doo-Byoung Oh; Kyung-A Hwang; Hilary Koprowski; Yong Seong Lee; Kisung Ko
Journal:  PLoS One       Date:  2013-08-15       Impact factor: 3.240

9.  Changes in total plasma and serum N-glycome composition and patient-controlled analgesia after major abdominal surgery.

Authors:  Ivan Gudelj; Marco Baciarello; Ivo Ugrina; Manuela De Gregori; Valerio Napolioni; Pablo M Ingelmo; Dario Bugada; Simona De Gregori; Lovorka Đerek; Maja Pučić-Baković; Mislav Novokmet; Olga Gornik; Gloria Saccani Jotti; Tiziana Meschi; Gordan Lauc; Massimo Allegri
Journal:  Sci Rep       Date:  2016-08-09       Impact factor: 4.379

Review 10.  Human plasma protein N-glycosylation.

Authors:  Florent Clerc; Karli R Reiding; Bas C Jansen; Guinevere S M Kammeijer; Albert Bondt; Manfred Wuhrer
Journal:  Glycoconj J       Date:  2015-11-10       Impact factor: 2.916

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.